Anna Beronius

Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Artiklar

Article: ENVIRONMENT INTERNATIONAL. 2025;197:109352
Using transcriptomics data and Adverse Outcome Pathway networks to explore endocrine disrupting properties of Cadmium and PCB-126
Wiklund L; Wincent E; Beronius A
Article: ENVIRONMENTAL SCIENCES EUROPE. 2025;37(1):19
Impact of the new hazard classes in the CLP regulation on EU chemicals legislation
Kattstrom D; Beronius A; af Gennas UB; Ruden C; Agerstrand M
Article: EVIDENCE-BASED TOXICOLOGY. 2024;2(1):2371285
Cross-mapping of terms used in chemical risk assessment with those used in systematic review: research protocol.
Svendsen C; Mathisen GH; Vist GE; Husøy T; Ames HM; Beronius A; Di Consiglio E; Druwe I; Hartung T; Hoffmann S; Hooijmans CR; Machera K; Robinson JF; Roggen E; Rooney AA; Roth N; Spilioti E; Spyropoulou A; Tcheremenskaia O; Testai E; Vinken M; Whaley P
Journal article: EVIDENCE-BASED TOXICOLOGY. 2024;2(1):2418045
A comprehensive item bank of internal validity issues of relevance to in vitro toxicology studies.
Vist GE; Ames HMR; Mathisen GH; Husøy T; Svendsen C; Beronius A; Consiglio ED; Druwe IL; Hartung T; Hoffmann S; Hooijmans CR; Machera K; Prieto P; Robinson JF; Roggen E; Rooney AA; Roth N; Spilioti E; Spyropoulou A; Tcheremenskaia O; Testai E; Vinken M; Whaley P
Article: ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY. 2024;43(11):2329-2337
AOP Report: An Upstream Network for Reduced Androgen Signaling Leading to Altered Gene Expression of Androgen Receptor-Responsive Genes in Target Tissues
Draskau MK; Rosenmai AK; Bouftas N; Johansson HKL; Panagiotou EM; Holmer ML; Elmelund E; Zilliacus J; Beronius A; Damdimopolou P; van Duursen M; Svingen T
Article: REPRODUCTIVE TOXICOLOGY. 2024;128:108662
Methodology for developing data-rich Key Event Relationships for Adverse Outcome Pathways exemplified by linking decreased androgen receptor activity with decreased anogenital distance
Holmer ML; Zilliacus J; Draskau MK; Hlisnikova H; Beronius A; Svingen T
Journal article: TOXICOLOGY LETTERS. 2024;399:s262
Development of an IATA for antiandrogen endocrine disruption
Beronius A; Vinggaard AM; Katsiadaki I; Bajard L; Mustafa E; Roncaglioni A; Sebire M; Spilioti E; Spyropoulou A; Sovadinova I; Knapen D; Jacobs M
Journal article: TOXICOLOGY LETTERS. 2024;399:s293
Developing the SciRAPepi tool for assessment of reliability and relevance of observational epidemiological studies
Hlisnikova H; Beronius A
Article: TOXICOLOGY. 2024;504:153794
Exploring a mechanism-based approach for the identification of endocrine disruptors using Adverse Outcome Pathways (AOPs) and New Approach Methodologies (NAMs) : A perfluorooctane sulfonic acid case study
Wiklund L; Pipal M; Weiss J; Beronius A
Article: ENVIRONMENTAL SCIENCE-PROCESSES & IMPACTS. 2024;26(2):380-399
Applying a modified systematic review and integrated assessment framework (SYRINA) - a case study on triphenyl phosphate
Bui TT; Aasa J; Abass K; Agerstrand M; Beronius A; Castro M; Escriva L; Galizia A; Gliga A; Karlsson O; Whaley P; Yost E; Ruden C
Article: HUMAN AND ECOLOGICAL RISK ASSESSMENT. 2024;30(1-2):122-137
Out of REACH: environmental hazards of cosmetic preservatives
Kattstrom D; Beronius A; af Gennas UB; Ruden C; Agerstrand M
Article: ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION. 2024;41(2):233-247
Beyond Chemicals: Opportunities and Challenges of Integrating Non-chemical Stressors in Adverse Outcome Pathways
Clerbaux L-A; Filipovska J; Nymark P; Chauhan V; Sewald K; Alb M; Sachana M; Beronius A; Amorim M-J; Wittwehr C
Article: FRONTIERS IN TOXICOLOGY. 2024;6:1357717
Building an adverse outcome pathway network for estrogen-, androgen- and steroidogenesis-mediated reproductive toxicity
Zilliacus J; Draskau MK; Johansson HKL; Svingen T; Beronius A
Article: FRONTIERS IN TOXICOLOGY. 2024;6:1452065
Fulfilling the criteria for CLP classification: the implications for substances under the EU chemicals legislation
Kattstrom D; Beronius A; Gennaes UBA; Ruden C; Agerstrand M
Article: OPEN RESEARCH EUROPE. 2024;4:68
Enhanced identification of endocrine disruptors through integration of science-based regulatory practices and innovative methodologies: The MERLON Project.
Svingen T; Andersson A-M; Angelova J; Axelstad M; Bakker J; Baumann L; Beronius A; Bouftas N; Chalmel F; Christiansen S; Cornil C; Damdimopoulou P; Deepika D; Dollé MET; Draskau MK; Fischer MB; Hagen CP; Hessel E; Holmer ML; Hughes S; Jensen G; Johansson HKL; Juul A; Kumar V; Kumar S; Lardenois A; Main KM; Mazaud-Guittot S; Moe SJ; Mola G; Parent A-S; Pineda R; Rolland A; Rosenmai AK; Song Y; Suglia A; Tena-Sempere M; Wehrli L; Zilliacus J; van Duursen M
Journal article: EVIDENCE-BASED TOXICOLOGY. 2023;1(1):2293289
Protocol: Testing the Performance of INVITES-IN, A Tool for Assessing the Internal Validity of In Vitro Studies
Mathisen GH; Vist GE; Whaley P; White RA; Husøy T; Ames HM; Beronius A; Di Consiglio E; Druwe I; Hartung T; Hoffmann S; Hooijmans CR; Machera K; Prieto P; Robinson JF; Roggen E; Rooney AA; Roth N; Spilioti E; Spyropoulou A; Tcheremenskaia O; Testai E; Vinken M; Svendsen C
Article: EVIDENCE-BASED TOXICOLOGY. 2023;1(1):2232415-15
Protocol for designing INVITES-IN, a tool for assessing the internal validity of in vitro studies.
Svendsen C; Whaley P; Vist GE; Husøy T; Beronius A; Consiglio ED; Druwe I; Hartung T; Hatzi VI; Hoffmann S; Hooijmans CR; Machera K; Robinson JF; Roggen E; Rooney AA; Roth N; Spilioti E; Spyropoulou A; Tcheremenskaia O; Testai E; Vinken M; Mathisen GH
Article: FRONTIERS IN TOXICOLOGY. 2023;5:1319985
SciRAPnano: a pragmatic and harmonized approach for quality evaluation of in vitro toxicity data to support risk assessment of nanomaterials
Shao G; Beronius A; Nymark P
Article: FRONTIERS IN TOXICOLOGY. 2023;5:1183824
Development of a data-driven approach to Adverse Outcome Pathway network generation: a case study on the EATS-modalities
Wiklund L; Caccia S; Pipal M; Nymark P; Beronius A
Article: ENVIRONMENTAL SCIENCES EUROPE. 2022;34(1):83
Characterisation and analysis of key studies used to restrict substances under REACH
Borchert F; Beronius A; Agerstrand M
Journal article: EFSA SUPPORTING PUBLICATIONS. 2022;19(7)
Training courses in risk assessment methodologies: uncertainty analysis, weight of evidence assessment and assessment of biological relevance
Beronius A; Craig P; Hanberg A; Hart A; Sahlin U; Zilliacus J
Article: TOXICOLOGY. 2022;476:153255
Systematic evaluation of the evidence for identification of endocrine disrupting properties of Bisphenol F
Wiklund L; Beronius A
Article: EFSA JOURNAL. 2022;20(Suppl 1):e200418
Assessment of endocrine disruptive properties of PFOS: EFSA/ECHA guidance case study utilising AOP networks and alternative methods
Pipal M; Wiklund L; Caccia S; Beronius A
Journal article: EFSA SUPPORTING PUBLICATIONS. 2022;19(5)
Evaluation of EFSA training courses on principles in chemical and biological risk assessment
Escher SE; Bruer G; Creutzenberg O; Schlemminger K; Schulz F; Ziemann C; Rorije E; van Klaveren J; Posthuma L; Bokkers B; Slob W; Hanberg A; Beronius A; Baumann L; Zilliacus J; Bitsch A
Article: CURRENT RESEARCH IN TOXICOLOGY. 2022;3:100065
Development of an adverse outcome pathway for intrahepatic cholestasis of pregnancy
Waspe J; Beronius A
Journal article: EMERGING CONTAMINANTS. 2022;8:229-242
Stricter regulation applies to antimicrobial substances when used as biocides compared to cosmetics under current EU legislation
Kattstrom D; Beronius A; Ruden C; Agerstrand M
Article: ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION. 2022;39(2):322-335
COVID-19 through Adverse Outcome Pathways: Building Networks to Better Understand the Disease-3rd CIAO AOP Design Workshop
Clerbaux L-A; Amigo N; Amorim MJ; Bal-Price A; Leite SB; Beronius A; Bezemer GFG; Bostroem A-C; Carusi A; Coecke S; Concha R; Daskalopoulos EP; Debernardi F; Edrosa E; Edwards SW; Filipovska J; Garcia-Reyero N; Gavins FNE; Halappanavar S; Hargreaves AJ; Hogberg HT; Huynh MT; Jacobson D; Josephs-Spaulding J; Kim YJ; Kong HJ; Krebs CE; Lam A; Landesmann B; Layton AR; Lee YO; Macmillan DS; Mantovani A; Margiotta-Casaluci L; Martens M; Masereeuw R; Mayasich SA; Mei LM; Mortensen H; Munoz A; Nymark P; Ohayon E; Ojasi JM; Paini A; Parissis N; Parvatam S; Pistollato F; Sachana M; Sorli JB; Sullivan KM; Sund J; Tanabe S; Tsaioun K; Vinken M; Viviani L; Waspe J; Willett C; Wittwehr C
Article: TOXICOLOGY. 2021;458:152843
An adverse outcome pathway on the disruption of retinoic acid metabolism leading to developmental craniofacial defects
Menegola E; Veltman CHJ; Battistoni M; Di Renzo F; Moretto A; Metruccio F; Beronius A; Zilliacus J; Kyriakopoulou K; Spyropoulou A; Machera K; van der Ven LTM; Luijten M
Article: ENVIRONMENTAL HEALTH. 2021;20(1):48
Assessment of the endocrine disrupting properties of bisphenol AF: a case study applying the European regulatory criteria and guidance
Escriva L; Zilliacus J; Hessel E; Beronius A
Article: ENVIRONMENT INTERNATIONAL. 2020;143:105926
Recommendations for the conduct of systematic reviews in toxicology and environmental health research (COSTER)
Whaley P; Aiassa E; Beausoleil C; Beronius A; Bilotta G; Boobis A; de Vries R; Hanberg A; Hoffmann S; Hunt N; Halsall C; Kwiatkowski CF; Lam J; Lipworth S; Martin O; Randall N; Rhomberg L; Rooney AA; Schunemann HJ; Wikoff D; Wolffe T; Halsall C
Article: ENVIRONMENT INTERNATIONAL. 2020;142:105828
A validated search filter for the identification of endocrine disruptors based on the ECHA/EFSA guidance recommendations
Escriva L; Hessel E; Gustafsson S; van Spronsen R; Svanberg M; Beronius A
Article: FOOD AND CHEMICAL TOXICOLOGY. 2020;143:111520
Methodology for health risk assessment of combined exposures to multiple chemicals
Beronius A; Zilliacus J; Hanberg A; Luijten M; van der Voet H; van Klaveren J
Article: FOOD AND CHEMICAL TOXICOLOGY. 2020;138:111185
The MCRA toolbox of models and data to support chemical mixture risk assessment
van der Voet H; Kruisselbrink JW; de Boer WJ; van Lenthe MS; van den Heuvel JJBH; Crepet A; Kennedy MC; Zilliacus J; Beronius A; Tebby C; Brochot C; Luckert C; Lampen A; Rorije E; Sprong C; van Klaveren JD
Article: HUMAN AND ECOLOGICAL RISK ASSESSMENT. 2020;26(1):212-241
Improving structure and transparency in reliability evaluations of data under REACH: suggestions for a systematic method
Ingre-Khans E; Agerstrand M; Ruden C; Beronius A
Article: EFSA JOURNAL. 2019;17(Suppl 2):e170914
Assessment of the endocrine disrupting properties of Bisphenol AF according to the EU criteria and ECHA/EFSA guidance
Escriva L; Hanberg A; Zilliacus J; Beronius A
Article: INTEGRATED ENVIRONMENTAL ASSESSMENT AND MANAGEMENT. 2019;15(3):458-469
Toxicity studies used in registration, evaluation, authorisation and restriction of chemicals (REACH): How accurately are they reported?
Ingre-Khans E; Agerstrand M; Beronius A; Ruden C
Article: TOXICOLOGY RESEARCH. 2019;8(1):46-56
Reliability and relevance evaluations of REACH data
Ingre-Khans E; Agerstrand M; Beronius A; Ruden C
Article: JOURNAL OF APPLIED TOXICOLOGY. 2018;38(12):1460-1470
Testing and refining the Science in Risk Assessment and Policy (SciRAP) web-based platform for evaluating the reliability and relevance of in vivo toxicity studies
Beronius A; Molander L; Zilliacus J; Ruden C; Hanberg A
Article: JOURNAL OF APPLIED TOXICOLOGY. 2018;38(5):783-785
A call for action: Improve reporting of research studies to increase the scientific basis for regulatory decision-making
Agerstrand M; Christiansen S; Hanberg A; Ruden C; Andersson L; Andersen S; Appelgren H; Bjorge C; Clausen IH; Eide DM; Hartmann NB; Husoy T; Halldorsson HP; van der Hagen M; Ingre-Khans E; Lillicrap AD; Beltoft VM; Mork A-K; Murtomaa-Hautala M; Nielsen E; Olafsdottir K; Palomaki J; Papponen H; Reiler EM; Stockmann-Juvala H; Suutari T; Tyle H; Beronius A
Article: TOXICOLOGY RESEARCH. 2017;6(5):571-577
Making the most of expert judgment in hazard and risk assessment of chemicals
Beronius A; Agerstrand M
Article: JOURNAL OF APPLIED TOXICOLOGY. 2017;37(3):319-330
Combining web-based tools for transparent evaluation of data for risk assessment: developmental effects of bisphenol A on the mammary gland as a case study
Molander L; Hanberg A; Ruden C; Agerstrand M; Beronius A
Article: ENVIRONMENTAL SCIENCE-PROCESSES & IMPACTS. 2016;18(12):1508-1518
Transparency of chemical risk assessment data under REACH
Ingre-Khans E; Agerstrand M; Beronius A; Ruden C
Article: ENVIRONMENTAL HEALTH. 2016;15(1):74
A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals
Vandenberg LN; Agerstrand M; Beronius A; Beausoleil C; Bergman A; Bero LA; Bornehag C-G; Boyer CS; Cooper GS; Cotgreave I; Gee D; Grandjean P; Guyton KZ; Hass U; Heindel JJ; Jobling S; Kidd KA; Kortenkamp A; Macleod MR; Martin OV; Norinder U; Scheringer M; Thayer KA; Toppari J; Whaley P; Woodruff TJ; Ruden C
Journal article: EFSA SUPPORTING PUBLICATIONS. 2016;13(5)
Review of non‐monotonic dose‐responses of substances for human risk assessment
Beausoleil C; Beronius A; Bodin L; Bokkers BGH; Boon PE; Burger M; Cao Y; De Wit L; Fischer A; Hanberg A; Leander K; Litens‐Karlsson S; Rousselle C; Slob W; Varret C; Wolterink G; Zilliacus J
Article: HUMAN AND ECOLOGICAL RISK ASSESSMENT. 2015;21(3):753-762
Science in Risk Assessment and Policy (SciRAP): An Online Resource for Evaluating and Reporting In Vivo (Eco)Toxicity Studies
Molander L; Agerstrand M; Beronius A; Hanberg A; Ruden C
Article: CURRENT OPINION IN PHARMACOLOGY. 2014;19:99-104
Bridging the gap between academic research and regulatory health risk assessment of Endocrine Disrupting Chemicals
Beronius A; Hanberg A; Zilliacus J; Ruden C
Journal article: REPRODUCTIVE TOXICOLOGY. 2014;48:18
How can academic research studies fill important information gaps in regulatory risk assessment? – The example of developmental neurotoxicity of bisphenol A
Beronius A
Article: JOURNAL OF APPLIED TOXICOLOGY. 2014;34(6):607-617
Facilitating the use of non-standard in vivo studies in health risk assessment of chemicals: a proposal to improve evaluation criteria and reporting
Beronius A; Molander L; Ruden C; Hanberg A
Article: TOXICOLOGY. 2013;311(1-2):13-26
The influence of study design and sex-differences on results from developmental neurotoxicity studies of bisphenol A, implications for toxicity testing
Beronius A; Johansson N; Ruden C; Hanberg A
Article: REPRODUCTIVE TOXICOLOGY. 2010;29(2):132-146
Risk to all or none? A comparative analysis of controversies in the health risk assessment of Bisphenol A
Beronius A; Ruden C; Hakansson H; Hanberg A
Article: REGULATORY TOXICOLOGY AND PHARMACOLOGY. 2009;55(2):111-122
Health risk assessment procedures for endocrine disrupting compounds within different regulatory frameworks in the European Union
Beronius A; Ruden C; Hanberg A; Hakansson H
Visa fler

Alla övriga publikationer

Conference publication: TOXICOLOGY LETTERS. 2024;399:s254-s255
Integration of transcriptomics data for ED assessments using an Adverse Outcome Pathway Network approach
Wiklund L; Vincent E; Beronius A
Conference publication: TOXICOLOGY LETTERS. 2023;384:s256-S262
P22-31: Training the next-generation toxicologists
Hanberg A; Dreij K; Beronius A; Karlsson H; Wincent E; Nymark P; Zilliacus J
Conference publication: TOXICOLOGY LETTERS. 2023;384:s77-S80
P01-10: Adverse outcome pathway network for endocrine disruption targeting estrogen, androgen and steroidogensis modalities – aspects for methodology development
Zilliacus J; Draskau MK; Johansson HK; Rosenmai AK; Christiansen S; Elmelund E; Holmer ML; Damdimopoulou P; Panagiotou EM; van Duursen M; Bouftas N; Svingen T; Beronius A
Conference publication: TOXICOLOGY LETTERS. 2023;384:s310-S317
LP-25: The curious case of Adverse Outcome Pathways: the stressor agnostic approach bridging disciplines by embracing evidence from diverse initiating factors
Filipovska J; Clerbaux L-A; Carusi A; Amorim M-J; Nymark P; Chauhan V; Sachana M; Beronius A; Edwards SW; Wittwehr C
Review: ENVIRONMENTAL RESEARCH. 2023;217:114650
Application of AOPs to assist regulatory assessment of chemical risks - Case studies, needs and recommendations
Bajard L; Adamovsky O; Audouze K; Baken K; Barouki R; Beltman JB; Beronius A; Bonefeld-Jorgensen EC; Cano-Sancho G; de Baat ML; Di Tillio F; Fernandez MF; FitzGerald RE; Gundacker C; Hernandez AF; Hilscherova K; Karakitsios S; Kuchovska E; Long M; Luijten M; Majid S; Marx-Stoelting P; Mustieles V; Negi CK; Sarigiannis D; Scholz S; Sovadinova I; Stierum R; Tanabe S; Tollefsen KE; van den Brand AD; Vogs C; Wielsoe M; Wittwehr C; Blaha L
Conference publication: TOXICOLOGY LETTERS. 2023;384:S77
Adverse outcome pathway network for endocrine disruption targeting estrogen, androgen and steroidogensis modalities - aspects for methodology development
Zilliacus J; Draskau MK; Johansson HK; Rosenmai AK; Christiansen S; Elmelund E; Holmer ML; Damdimopoulou P; Panagiotou EM; van Duursen M; Bouftas N; Svingen T; Beronius A
Conference publication: TOXICOLOGY LETTERS. 2023;384:S310
The curious case of Adverse Outcome Pathways: the stressor agnostic approach bridging disciplines by embracing evidence from diverse initiating factors
Filipovska J; Clerbaux L-A; Carusi A; Amorim M-J; Nymark P; Chauhan V; Sachana M; Beronius A; Edwards SW; Wittwehr C
Conference publication: TOXICOLOGY LETTERS. 2023;384:S256
Training the next-generation toxicologists
Hanberg A; Dreij K; Beronius A; Karlsson H; Wincent E; Nymark P; Zilliacus J
Conference publication: TOXICOLOGY LETTERS. 2022;368:S3
Introduction to regulatory toxicology, different steps in risk assessment
Beronius A
Conference publication: TOXICOLOGY LETTERS. 2022;368:S268
Towards AOP-driven next generation assessment of endocrine disruptors
Wiklund L; Pipal M; Caccia S; Beronius A
Review: JOURNAL OF CLINICAL MEDICINE. 2022;11(15):4464
Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
Clerbaux L-A; Albertini MC; Amigo N; Beronius A; Bezemer GFG; Coecke S; Daskalopoulos EP; del Giudice G; Greco D; Grenga L; Mantovani A; Munoz A; Omeragic E; Parissis N; Petrillo M; Saarimaki LA; Soares H; Sullivan K; Landesmann B
Preprint: PREPRINTS.ORG. 2022
Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
Clerbaux L-A; Albertini MC; Amigó N; Beronius A; Bezemer GFG; Coecke S; Daskalopoulos EP; Del Giudice G; Greco D; Grenga L; Mantovani A; Muñoz A; Omeragic E; Parissis N; Petrillo M; Saarimäki LA; Soares H; Sullivan K; Landesmann B
Editorial comment: FRONTIERS IN TOXICOLOGY. 2022;4:1056285
Editorial: Women in regulatory toxicology: 2021
Agerstrand M; Beronius A; Junghans M; Martin O
Conference publication: TOXICOLOGY LETTERS. 2021;350:S213
Collection and initial analysis of evidence to assess endocrine disrupting properties of Bisphenol F
Wiklund L; Beronius A
Conference publication: TOXICOLOGY LETTERS. 2021;350:S38
Novel means of enabling high-throughput toxicogenomics and adverse outcome pathways for prediction of lung toxicity
Nymark P; Martens M; Willighagen E; Hongisto V; Kohonen P; Grafstrom RC; Beronius A; Halappanavar S
Review: FRONTIERS IN TOXICOLOGY. 2021;3:746430
Development of the SciRAP Approach for Evaluating the Reliability and Relevance of in vitro Toxicity Data
Roth N; Zilliacus J; Beronius A
Review: ENVIRONMENT INTERNATIONAL. 2021;146:106103
Evaluating reliability and risk of bias of in vivo animal data for risk assessment of chemicals - Exploring the use of the SciRAP tool in a systematic review context
Waspe J; Bui T; Dishaw L; Kraft A; Luke A; Beronius A
Conference publication: TOXICOLOGY LETTERS. 2019;314:S253
Systematic evaluation of in vitro data for hazard and risk assessment - development of the SciRAP tool
Beronius A; Zilliacus J
Conference publication: TOXICOLOGY LETTERS. 2019;314:S22-S23
Principles of systematic approaches for chemical risk assessment
Hanberg A; Zilliacus J; Beronius A
Conference publication: TOXICOLOGY LETTERS. 2019;314:S263
EuroMix handbook for mixture risk assessment
Zilliacus J; Beronius A; Hanberg A; Luijten M; van der Voet H; van Klaveren J
Conference publication: TOXICOLOGY LETTERS. 2019;314:S246
Assessment of bisphenol AF as an endocrine disruptor
Escriva L; Hanberg A; Zilliacus J; Beronius A
Review: CRITICAL REVIEWS IN TOXICOLOGY. 2018;48(9):796-814
Overview on legislation and scientific approaches for risk assessment of combined exposure to multiple chemicals: the potential EuroMix contribution
Rotter S; Beronius A; Boobis AR; Hanberg A; van Klaveren J; Luijten M; Machera K; Nikolopoulou D; van der Voet H; Zilliacus J; Solecki R
Review: TOXICOLOGY AND APPLIED PHARMACOLOGY. 2018;339:10-23
Evaluating the evidence for non-monotonic dose-response relationships: A systematic literature review and (re-)analysis of in vivo toxicity data in the area of food safety
Varret C; Beronius A; Bodin L; Bokkers BGH; Boon PE; Burger M; De Wit-Bos L; Fischer A; Hanberg A; Litens-Karlsson S; Slob W; Wolterink G; Zilliacus J; Beausoleil C; Rousselle C
Conference publication: BIRTH DEFECTS RESEARCH. 2017;109(9):685
From Inhibition of Retinoic Acid Catabolism to Facial Malformations: Suggestions for a New Adverse Outcome Pathway
Di Renzo F; Moretto A; Eberini I; Beronius A; Zilliacus J; Hanberg A; Menegola E
Meeting abstract: TOXICOLOGY LETTERS. 2016;258:S302
Skeletal cranio-facial dysmorphogenesis: Suggestions for a new AOP
Di Renzo F; Moretto A; Battistoni M; Beronius A; Zilliacus J; Hanberg A; Menegola E
Review: ENVIRONMENT INTERNATIONAL. 2016;92-93:590-596
Weight of evidence evaluation and systematic review in EU chemical risk assessment: Foundation is laid but guidance is needed
Agerstrand M; Beronius A
Review: REVIEWS IN ENDOCRINE & METABOLIC DISORDERS. 2015;16(4):273-287
Using systematic reviews for hazard and risk assessment of endocrine disrupting chemicals
Beronius A; Vandenberg LN
Meeting abstract: TOXICOLOGY LETTERS. 2015;238(2):s117-s118
Transparency and accessibility of data within REACH
Ingre-Khans E; Agerstrand M; Beronius A; Ruden C
Meeting abstract: TOXICOLOGY LETTERS. 2015;238(2):s42
A proposal for systematic review and assessment of endocrine disruption
Beronius A; Agerstrand M; Ruden C; Bergman A
Meeting abstract: TOXICOLOGY LETTERS. 2015;238(2):S128
A characterization of dose-response relationships for developmental effects of bisphenol A (BPA) in the low dose range
Molander L; Beronius A; Hanberg A; Agerstrand M; Ruden C
Meeting abstract: TOXICOLOGY LETTERS. 2013;221:S36
Risk to all or none? The Bisphenol A risk controversy
Beronius A
Meeting abstract: TOXICOLOGY LETTERS. 2013;221:S224
Facilitating the use of non-standard in vivo studies in health risk assessment-A proposal to improve evaluation criteria and reporting
Molander L; Beronius A; Ruden C; Hanberg A
Doctoral thesis: 2013
Risk assessment of endocrine disrupting compounds
Beronius A
Meeting abstract: TOXICOLOGY LETTERS. 2012;211:S128-S129
Factors influencing developmental neurotoxicity study outcome in the bisphenol A case
Beronius A; Willighagen E; Ruden C; Hanberg A
Meeting abstract: TOXICOLOGY LETTERS. 2012;211:S130
Endpoints and dose-response relationships of low-dose studies of Bisphenol A
Molander L; Beronius A; Hanberg A; Ruden C
Meeting abstract: TOXICOLOGY LETTERS. 2011;205:S256
Improving the transparency of data evaluation in risk assessment of endocrine disrupting compounds-Implications from the bisphenol A case study
Beronius A; Ruden C; Hanberg A
Book chapter: ENDOCRINE DISRUPTING CHEMICALS IN FOOD. 2009;p.
Assessing the risks of endocrine-disrupting chemicals
Rudén C; Hanberg A; Håkansson H; Garai J; Beronius A
Book chapter: ENDOCRINE-DISRUPTING CHEMICALS IN FOOD. 2009;p. 356-380
14 Assessing the risks of endocrine-disrupting chemicals
Beronius A; Ruden C; Hanberg A; Garai J; Hakansson H
Visa fler

Forskningsbidrag

MERLON - Merging scientific evidence with regulatory practices and leveraging identification of endocrine disruptors using new approach methodologies
European Commission
1 January 2024 - 31 December 2028
INQUIRE: Identification of chemical and biological determinants, their sources, and strategies to promote healthier homes in Europe
Horison Europe
1 September 2022 - 31 August 2027
PARC - Partnership for the Assessment of Risks from Chemicals
European Commission
1 May 2022 - 30 April 2029
A novel mechanism-based approach for assessment of developmental toxicity of endocrine disruptors
FORMAS
1 January 2021 - 31 December 2024
A novel mechanism-based approach for assessment of developmental toxicity of endocrine disruptors
Swedish Research Council for Environment Agricultural Sciences and Spatial Planning
1 January 2021 - 31 December 2024
Alternative methods for developmental toxicity testing
Swedish Research Council
1 January 2018 - 31 December 2020
SciRAP – a way to improved risk assessment of chemicals.
Swedish Research Council for Environment Agricultural Sciences and Spatial Planning
1 January 2016 - 30 April 2016

Anställningar

Senior Forskare, Institutet för miljömedicin, Karolinska Institutet, 2025-
Senior Forskningsspecialist, Institutet för miljömedicin, Karolinska Institutet, 2022-2025

Examina och utbildning

Docent, Toxikologi, Karolinska Institutet, 2022
Medicine Doktorsexamen, Institutet för miljömedicin, Karolinska Institutet, 2013

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI